Despite the current pandemic context, the organizing committee of Journée Phare 2021 is pleased to announce that the Journée Phare 2021 will take place on February 4th and 5th in virtual format on the Fourwaves platform!
Lasting two days, the Phare Day will seek to bring together students, researchers, research professionals and members of the industry to discuss recent discoveries in different fields of health science research. The perfect opportunity to form new networks of contacts and develop scientific communication skills in a friendly atmosphere, this will be an event not to be missed!
The organizing committee of the 2021 Phare Day
The organizing committee for the Journée Phare is very happy to announce that John Bell has agreed to be a speaker at the 2019 Phare Day!
Pr John Bell
Departments of medicine and biochemistry, microbiology & immunology,
University of Ottawa
John Bell is a professor in the departments of medicine and biochemistry, microbiology & immunology at the University of Ottawa and a senior scientist at the Ottawa Hospital Research Institute. Over the course of the last 30 years, his laboratory has developed a cutting-edge expertise in the use of viruses as treatments against cancer, leading to more than 200 papers published in high impact journals. He also heads the Canadian Oncolytic Virus Consortium, a Terry Fox funded group from across Canada that is developing virus-based cancer therapeutics and is the director of the Biotherapeutics Program for the Ontario Institute for Cancer Research. He is the Scientific Director of the National Centre of Excellence for the development of Biotherapeutics for Cancer Therapy and is a fellow of the Royal Society of Canada.
The organizing committee for the Journée Phare 2019 is very pleased to introduce our participants to the discussion panel that will follow the presentation of Professor Yann Joly in the context of the bioethics workshop 101: Issues and perspective in the 21st century
BiogeniQ’s Vice President of Scientific Affairs
Michel Cameron is BiogeniQ’s Vice President of Scientific Affairs since 2014. BiogeniQ is a company dedicated to improving the patient’s treatment and well-being by using their genetic information. He first obtained a master’s degree in biology from the University of Queens and a Ph.D. in pharmacology from the Université de Montréal. He has also completed a post-doctorate at the Montreal Heart Institute and is also Director of Pharmacogenomics at Biron.
Université de Sherbrooke
Benoit Leblanc is a lecturer in the Department of Biology at the Université de Sherbrooke. He is particularly known for the quality of his teaching and his great talents as an popularizer. He participated in the Sherbrooke edition of Pinte de Science in 2016 and led several discussions following the presentation of scientific documentaries (Food Evolution, Giving his body to science). He is also known for his talent as a comic book artist that he shares on his blog (http://gensenblouseblanche.blogspot.com/).
CIUSSS de l’Estrie-CHUS
Annabelle Cumyn is a McGill-certified internal medicine specialist who has been practicing obstetric medicine at CIUSSS in Estrie-CHUS since 2017. She also has a Masters in Health Sciences Pedagogy from the University of Illinois in Chicago. His research interests are in curriculum development and research ethics. She is currently Chair of the Human Health Research Ethics Committee of the CHUS and the Research Ethics Committee (CER) of the CIUSSS of Estrie-CHUS and is a member of the research ethics of the Three Canadian Councils.
The organizing committee for the Journée Phare is very happy to announce that Marc-André D’Aoust has agreed to be a speaker at the 2019 Phare Day!
Marc-André D’Aoust received his PhD in Plant Biochemistry and Molecular Biology from Université Laval. He started his career at Medicago in 1999 as team manager. He subsequently worked as a product development project director and senior director for research and innovation. He later became Vice President of Research and Innovation at the same company in 2014. He is responsible for overseeing research and development activities related to the vaccine production platform and associated generic technologies. He led the discovery and development of the transient protein expression system, including transient plant-based expression technology, influenza-like particle production, and the VLPExpress high-throughput discovery platform.
The organizing committee for the Journée Phare is very happy to announce that Pr. Philippe Gros has accepted to be a speaker at the Journée Phare 2019!
Pr Philippe Gros
Department of Biochemistry,
Professor Philippe Gros has been a professor in the Department of Biochemistry at McGill University since 1993. His research focuses on the study of new genes, proteins or pathways that can lead to complex genetic diseases using murine models, particularly infectious diseases, spina bifida and cancer. It is in fact his research on malaria that allowed him to be part of the 10 discoveries of the year 2018 according to the magazine Quebec Science. To do this, his research team has found a molecule that can fight Plasmodium falciparum and treat cerebral malaria, one of the most dangerous complications of malaria. In addition, he has published over 250 scientific articles in prestigious scientific journals and received the McLaughlin Medal for Scientific Excellence from the Royal Society of Canada in 2014.
The organizing committee for the Phare Day is very happy to announce that Professor Yann Joly has agreed to be a speaker at the 2019 Phare Day!
Pr Yann Joly
Department of Human Genetics,
Yann Joly is the research director at the Center for Genomics and Policy (CGP) and Associate Professor in the Department of Human Genetics at McGill University. In addition to having a Ph.D, Pr. Joly is also a lawyer and was awarded the Barreau du Québec’s Avocat émérite distinction in 2012. He is also president of the International Human Epigenome Consortium’s Bioethics Working Group ( IHEC) as well as the Ethics and Governance Committee of the International Cancer Genome Consortium (ICGC). His research interests lie at the crossroads of health law (biotechnology and other emerging health technologies) and bioethics. He has published more than 120 scientifics articles in the fields of law, science and ethics. He also received the prestigious Barreau du Québec’s Merit Award (Innovations) in 2012 for his work in the right to privacy in the biomedical field.
Now that Journée Phare 2018 is over, we would like to thank you for your participation on November 15th and 16th. It was a congress rich in scientific discussions, and we hope you enjoyed it as much as we had fun organizing it. We would also like to congratulate all our winners here:
Oral presentation prizes
1st prize : Laurence Gagnon, McGill University
2nd prize : Maxime Gagnon, Université de Sherbrooke
Prix de présentations par affiche
1st prize : Béatrice Quirion, Université de Sherbrooke
2nd prize : Palina Piankova, McGill University
3rd prize : Sara El-Sahli, Ottawa University
Prix Relève : Simon Dumontier, undergraduate student, Université de Sherbrooke
Congratulations to all presenters!
Organizing committee of Journée Phare 2018
The Journée Phare 2018 organizing committee is very pleased to announce that we will be welcoming Pr. Reinhart Reithmeier at the 10th edition of the Journée Phare!
Reinhart Reithmeier is a Professor in the Department of Biochemistry at the University of Toronto and is known internationally for his research on membrane proteins in human health and disease. A dedicated mentor, he successfully trained 10 PhD students, 8 Master’s students and served on over 50 graduate supervisory committees. As Graduate Coordinator in the Institute of Medical Sciences and Biochemistry Dr. Reithmeier was a strong advocate for students. A former Chair of Biochemistry (2002-13) and Special Advisor to the Dean of Graduate Studies on Graduate Skills Development and Engagement (2015-17), he was dedicated to ensuring that graduate students develop their skills and professional network, and are fully prepared to take advantage of the diverse job opportunities available to them in today’s global marketplace. One of his notable initiatives in 2016 was completing the 10,000 PhDs Project, which determined the current positions of the 10,886 individuals who graduated with a PhD from the U of T from 2000 to 2015. An award-winning lecturer and graduate mentor, Dr. Reithmeier enjoys teaching introductory biochemistry to over 1,000 undergraduate students every year, as well as upper level and graduate courses. His leadership was recognized by election to the Canadian Academy of Health Sciences.
The Journée Phare 2018 organizing committee is very pleased to announce that we will be welcoming Pr. Vincenzo Di Marzo at the 10th edition of the Journée Phare!
Pr. Vincenzo Di Marzo
Director of the Institute of Biomolecular Chemistry of the National Research Council in Pozzuoli, Italy.
Chair in Research Excellence in Canada on the Microbiome-Endocannainoidome Axis in Metabolic Health, Université Laval.
Internationally renowned in the field of pharmacology of endocannabidoids, Pr. Di Marzo is co-author of more than 600 articles in scientific journals and has more than 50,000 citations. Prof. Di Marzo is listed in 2017 on the list of “Worlds Most Influential Scientific Minds” by the strategic information society Clarivate Analytics.
His research group is interested in the intestinal microbiome and its inflammatory role in the development of various diseases, such as obesity, type II diabetes and cardiovascular diseases. These health issues are ubiquitous in our societies, and the role of the microbiome in their development and deterioration is still unclear. Prof. Di Marzo’s work thus seeks to identify new targets and therapeutic approaches in the management of these complex disorders, with a marked interest for endocannabinoids, involved in many systems including the management of energy metabolism. Knowing that the microorganisms that inhabit the digestive tract vary according to the diet, they seek to know if it is possible to prevent or alter the development of different diseases by changing the diet.
The Journée Phare 2018 organizing committee is very pleased to announce that we will be welcoming Dr Reza Forghani at the 10th edition of the Journée Phare!
Reza Forghani is the Associate Director of the Department of Radiology at Montreal’s Jewish General Hospital and a researcher at the Lady Davis Institute. Dr. Forghani holds a medical degree and a doctorate from McGill University and has completed a Fellowship at Harvard Medical School and Massachusetts General Hospital. Dr. Forghani is an expert in neuroradiology and imaging for head and neck. Her research focuses on the use of artificial intelligence in cancer detection, to improve diagnostic accuracy and reduce the need for invasive biopsies. He is involved in the development of “Radiomics”, a field of medical study that combines data from both medical imaging and patient records. The combination of radiomics and artificial intelligence thus foreshadows a personalized medicine more effective in oncology. His work, at the meeting of basic science, clinical science, technology and biology, provides insight into the power of integrating innovations into health care.